YAP1 and neoplasm: By activating the Hippo signaling axis and blocking the nuclear translocation of YAP, EM2 significantly inhibits the proliferation, migration, invasion and tumor growth of NSCLC in cell, organoid and xenograft models, demonstrating excellent development potential (Figure9).